Collaboration. Acceleration. Results.
Myelin Repair Foundation Home Page

Media Archives


San Francisco Business Times, How a white powder couldn't pass U.S. Customs but could save MS patients, May 1, 2015
Case Western Reserve University - The Daily, Drugs stimulate body’s stem cells to replace the brain cells lost in multiple sclerosis, April 20, 2015
ScienceLife: The University of Chicago, Blood pressure drug protects against symptoms of multiple sclerosis in animal models, March 13, 2015
NeurologyNow, Getting at the Root of MS, December 2014 / January 2015
The New Exploratory Urge, May 2014
Life Science Leader, Life Science Partnerships With Patient Foundations: The Best Practices, June 2, 2014
Pharmaceutical Executive, Pushing the Boundaries of MS Research: The Myelin Repair Foundation, February 28, 2014
Multiple Sclerosis Discovery Forum, MS Research Roundup: February 12, 2014
BioNews Texas, Multiple Sclerosis Myelin Repair, Neuroprotection Drug To Be Tested In New Research Collaboration, February 3, 2014
Bio-IT World, January News and Product Briefs, January 2014
NeuroNews, Myelin Repair Foundation and NIH enter into agreement to repurpose MRF-008 for multiple sclerosis, January 29, 2014
BioNews Texas, Promising Multiple Sclerosis Study Involving NIH, Myelin Repair Foundation Seeks To Repurpose Hypertension Drug To Stimulate Repair In MS, January 28, 2014
San Francisco Business Times, A new way: Foundation lines up generic heart drug for multiple sclerosis trial, January 27, 2014
The New York Times, In the Long War on Poverty, Small Victories That Matter, January 8, 2014
Patient Pioneers — Biocentury TV, November 3, 2013
The Huffington Post, What Now: It Still Takes Too Long and Costs Too Much, October 31, 2013
Genetic Engineering & Biotechnology News, Biogen Idec, Myelin Repair Foundation Eye New Mouse Model Against MS, July 1, 2013
Neurology Now, Make It Better, June 2013
Genetic Engineering News, Top 20 Grant-Giving Disease Foundations, May 28, 2013
FierceBiotech, Foundations Fuel Risky Biotech Ventures, March 27, 2013
Philanthropic Intelligence, When your giving feels like just a drop in the bucket…a great Medical Research funding story, March 14, 2013
Brain Health Fair Coming to San Diego Saturday, March 16, March 13, 2013
FasterCures, Honest Brokers for Cures: How Venture Philanthropy Groups are changing biomedical research, March 5, 2013
SF Business Times, Benevolence meets market: Newly launched disease nonprofits quickly realize that kindness isn't enough, March 1, 2013
Forbes, Forbes Health Summit: How Patient Groups are Changing Biotech, February 5, 2013
The Burrill Report, Repairing What's Broken, January 28, 2013.
California Biomedical Industry 2013 Report: Developing New Products, January 2013.
2012 Forbes Healthcare Conference panel, When Patients Become Catalysts for Change
2012 Partnering for Cures Conference panel, Powered by Patients
New York Times, Moving Forward in Tough Times, December 12, 2012.
Nature SciBX, Micromanaging tolerance, December 6, 2012. (Subscription log-in required)
Businessweek, Speeding Up the Discovery of Drugs, November 29, 2012
Pharmaceutical Executive Magazine, Three Ways to the Future, October 1, 2012
Nerdwallet, NerdWallet's Top 6 Healthcare Innovation Nonprofits, September 13, 2012
Nature Biotechnology, Patient power, September 10, 2012 (Subscription log-in required)
Fast Company, A Look Around The Bend On The Health Innovation Highway, September 6, 2012
GEN: Genetic Engineering & Biotechnology News, Filling the Drug Translation Gap, August 29, 2012
Berkeley-Haas Magazine, "Finding a Cure," August 16, 2012.
BioTuesdays, "Leading the fight to repair myelin in MS patients," August 14, 2012.
The Atlantic, "Will Patients Bear the Burden for Developing Their Own Treatments?," May 10, 2012.
The Atlantic, "Mission Critical: How Disease-Specific Foundations May Save Medical Research," April 20, 2012.
San Francisco Business Times, "One-on-One with UCSF researcher Jonah Chan," April 19, 2012.
Huffington Post, "Hilary Rosen Should Donate to Multiple Sclerosis Foundations," April 12, 2012.
Silicon Valley/San Jose Business Journal, "Clinical trial to target multiple sclerosis," March 7, 2012.
Xconomy, "Disease foundations play growing role in biotech business model," March 6, 2012.
USA Today, "Parents of twins with rare disease fight for FDA approval of treatment," March 6, 2012.
Drug Discovery News, "Engendering the collaborative spirit to cure MS," March 2012.
Clinical trial examines Myelin Toleraization of the Immune System — Drug Discovery & Development Magazine, March 3, 2012.
Partnering for a Cure: Stanford Social Innovation Review features Ideas/First Person column by Scott Johnson, October 25, 2011.
California Health Institute blog posts Q&A with Scott Johnson about his personal mission to push the boundaries of biomedical collaboration, May 5, 2011.
NY Times columnist David Bornstein: "Serving as a kind of switchboard, where people from different disciplines and sectors converge, M.R.F. can recognize opportunities that might otherwise go unnoticed." Read more about how the Myelin Repair Foundation is crossing boundaries to accelerate research, May 5, 2011.
NY Times columnist David Bornstein: "The explosion in biomedical sciences has made it virtually impossible for industry researchers to keep up." Read more about how the Myelin Repair Foundation is part of the solution, May 2, 2011.
Fast Company, March 1, 2011: Myelin Repair Foundation Named Among Top 10 Biotechs.
Fast Company, Feburary 4, 2011: Online Game Crowdsources Ideas to Accelerate Medical Research
The Scientist features the Myelin Repair Foundation in an article that examines how nonprofit, for-profit pharma groups are working together to make drugs more affordable for developing countries. Read more: The Profits of Nonprofit, January 1, 2011.
Myelin Repair Foundation-hosted Breakthroughs to Cures named #7 among top 10 social impact games of 2010, December 31, 2010.
Myelin Repair Group Works to Develop Drugs, Cure MS, December 27, 2010.
Fast Company, November. 1, 2010: “The Myelin Repair Foundation Encourages Collaboration for a Cure”
Kauffman Foundation Translational Medicine Alliance 2010 Forum, Washington, DC. Scott Johnson spoke on the panel, Rethinking Everything: If we were starting over, what would we do differently with Jonathan Jacoby from The R.A.R.E. Project and Lt Col Daniel J. Wattendorf, MD from DARPA. October 13-14, 2010.
UC Davis Alumni Magazine, Fall 2010: Spotlight’s Scott Johnson’s work with the Myelin Repair Foundation
E-Week, Online Gaming Event Seeks to Spur Search for Cures to Intractable Diseases, September 30, 2010.
Huffington Post, Julia Moulden covers Breakthroughs to Cures, Sep. 25, 2010.
PBS Newshour, September 23, 2010: For Scientists, Collaborative Efforts Could Speed Medical Advances.
FierceBiotech Research, September 14, 2010: Foundation uses gaming to inspire rad R&D thinking.
Smart Business Northern California, July 2010: Engaging the Chain.
Newsweek, May 10, 2010: Desperately Seeking Cures, Mary Carmichael and Sharon Begley discuss how the road from promising scientific breakthrough to real-world remedy has become all but a dead end. The Myelin Repair Foundation is mentioned as a model for fixing the system.
Kansas City Business Journal, March 26, 2010: Ewing Marion Kauffman Foundation Continues Push For Commercializing Drugs.
Silicon Valley/San Jose Business Journal, October 16, 2009: Foundation’s research model in Saratoga aims to halve clinical trial time.
Forbes Magazine, July 13, 2009: What Brain Researchers Forgot Kerry Dolan discusses a recent discovery by one of our Principal Investigators, Ben Barres, on the role of glial cells. Because of the unique functions that these cells perform in the brain, Myelin Repair Foundation scientists hope to exploit their therapeutic potential in further studies., May 11, 2009: Company turns research process on its head.
Elizabeth Edersheim Blog, April 2009: Working Together to Heal., December 2008: Foundation Tests Entrepreneurial Model for Medical Research.
Newsweek On Science, November 2008: Where are the Cures? Scientists Call the Gulf between Biomedical Discovery and New Treatment the ‘Valley of Death.’
MS Focus Magazine, Summer 2008: Paths to Progress features Myelin Repair Foundation update on myelin repair research.
biotechTransfer week, June 4, 2008: Myelin Repair Foundation Taps CDD Software to Support ‘Accelerated’ Academic Research.
BusinessWeek, May 7, 2008: John Hagel and John Seely Brown review Myelin Repair Foundation’s ARC model in Innovation on the Edge.
San Francisco Chronicle, March 29, 2008: Non-Profit Gears Up for Biotech Roadshow.
The New Yorker, January 28, 2008: Buying a Cure.
We Are the New Radicals: A Manifesto for Reinventing Yourself and Saving the World features Myelin Repair Foundation President Scott Johnson as one of several "boomers" who has leveraged his career expertise to take on some of the world's toughest problems.
BusinessWeek, November 2007: Software that maps who is working on common problems is shaving years off research — and honing corporate strategies.
Dick Gordon, host of American Public Media's The Story, interviews Scott Johson about his multiple sclerosis diagnosis and the need for a new model that will speed the delivery of patient treatments for all diseases.
Scientific American Podcast: Scott Johnson tells listeners about the Myelin Repair Foundation's Accelerated Research Collaboration model. Listen here.
Fast Company magazine's FAST 50, March 2007: The Myelin Repair Foundation named as one of 50 "imaginative, entrepreneurial 'businesses'" who are stepping up to change the world.
In Vivo: The Business & Medicine Report, January 2007: Peter Lawyer, Senior Vice Predient in the Boston Consulting Group features Myelin Repair Foundation as a best-in-class model for time-based discovery.
Wall Street Journal: "Why Non-Profits Fund For-Profit Researchers," January 26, 2007. Myelin Repair Foundation COO Rusty Bromley comments on the need to "de-risk" drug targets for pharmaceutical companies.
Annals of Neurology: Vol 60 No 6 December 2006: Editors S. Claiborne Johnson, MD, PhD and Stephen L. Hauser, MD, report on the need for new models that will efficiently bridge the gaps between academia, industry and patient treatments.
Genome Biology, December 2006: A model worth considering is a commentary by Dr. Gregory A. Petsko, Professor of Biochemistry and Chemistry Protein Crystallography at Brandies University.
The Culture of Collaboration: Evan Rosen features the Myelin Repair Foundation's collaborative model along with best practices from Toyota, Proctor & Gamble, Dream Works and others in what Rosen called the "deserialization" of interaction and work.
In The Definitive Drucker, strategic consultant Elizabeth Haas Edershein presents Myelin Repair Foundation through the eyes of business management icon Peter Drucker in this latest "biography" of his ideas. [Chapter Four: Collaboration and Orchestration]
Scientific American names Scott Johnson among top 50 worldwide for leadership in science, business and policy innovations.
"California Gains Science and Tech Praise," November 6, 2006. KCBS-Radio News reports on Scientific American magazine's salute to Scott Johnson as one of 50 worldwide research, business and policy leaders.
Fortune Magazine: One Man's Crusade for a Cure, September 18, 2006. Fortune magazine profiles Myelin Repair Foundation founder and President Scott Johnson.

Press Releases

The Myelin Repair Foundation and Teva Pharmaceutical Industries Collaborate on Neuro-protection and Myelin Repair for the Treatment of Multiple Sclerosis (October 20, 2015)
The Myelin Repair Foundation and National Institutes of Health Initiate Clinical Studies of Guanabenz for Treatment of Multiple Sclerosis (April 30, 2015)
Blood pressure drug protects against symptoms of multiple sclerosis in animal models (March 13, 2015)
Conrad N. Hilton Foundation Grants Myelin Repair Foundation $1.35 Million Matching Grant to Support Myelin Repair Research (November 24, 2014)
Myelin Repair Foundation Announces Long-Term European Partnership with Hertie Foundation (August 11, 2014)
Bionure Inc.’s MS Drug Candidate Shows Positive Results for Myelin Repair in Cell Culture Assay (May 27, 2014)
The Myelin Repair Foundation and NIH Enter Agreement for the Clinical Development of MRF-008, a Drug Repurposing Opportunity for Multiple Sclerosis (January 27, 2014)
Dr. Ted Yednock Joins Myelin Repair Foundation’s Drug Discovery Advisory Board (December 5, 2013)
The Myelin Repair Foundation Enters First International Partnership with Bionure, Inc. (October 31, 2013)
Scott Johnson to Receive BayBio Award at 10th Annual Pantheon Ceremony (October 16, 2013)
The Myelin Repair Foundation Partners with Gencia Corporation to Advance Myelin Repair Therapeutics for Multiple Sclerosis (MS) (August 13, 2013)
Myelin Repair Foundation Grants License for Novel Mouse Model to Biogen Idec (July 1, 2013)
The Myelin Repair Foundation Announces Expansion of its Patent Portfolio (April 22, 2013)
The Myelin Repair Foundation Receives $2 Million Gift from Anonymous Trust to Accelerate Myelin Repair Therapeutics for Multiple Sclerosis (March 12, 2013)
Ballenger Trust Selects the Myelin Repair Foundation to Advance Myelin Repair Therapeutic Development for Multiple Sclerosis (December 18, 2012)
The Myelin Repair Foundation to Present at Partnering for Cures 2012 (November 28, 2012)
Nature Biotechnology Study Highlights New Myelin Specific Approach to Treat Multiple Sclerosis (November 19, 2012)
The Myelin Repair Foundation to Present at 11TH Annual BIO Investor Forum (October 5, 2012)
The Myelin Repair Foundation Launches Its Internship Program Examining the Clinical Drug Development Process in Phase 2 and 3 Clinical Trial Failures (August 30, 2012)
The Myelin Repair Foundation Achieves Phase 1 Myelin Repair Clinical Trial (June 14, 2012)
Nature Neuroscience Study Shows Unique Scientific Support for Potential New Myelin Repair Treatment for Multiple Sclerosis (May 20, 2012)
The Myelin Repair Foundation Welcomes University of California, San Francisco’s Dr. Jonah Chan to its Research Consortium (May 8, 2012)
Multiple Sclerosis Expert Dr. Alfred Sandrock from Biogen Idec Joins the Myelin Repair Foundation's Clinical Advisory Board (March 13, 2012)
Myelin Repair Foundation's President Scott Johnson awarded the Research!America Gordon and Llura Gund Leadership Award. (March 12, 2012)
Myelin Repair Foundation Research Fosters a Clinical Trial for Multiple Sclerosis. (March 7, 2012)
The Myelin Repair Foundation and ENDECE Neural Form Collaboration to Develop Myelin Regenerative Compounds for Multiple Sclerosis (MS) Treatment. (February 8, 2012)
Myelin Repair Foundation Launches the New Myelin Repair Foundation Translational Medicine Center. (January 4, 2012)
Research!America Honors Scott Johnson for Advocacy for Medical Research. (October 5, 2011)
Mice stem cells guided into myelinating cells by the trillions. (September 25, 2011)
Conrad N. Hilton Foundation Grants Myelin Repair Foundation $750,000 to advance human cell cultures for myelin repair. (September 20, 2011)
Fast Company Names the Myelin Repair Foundation Among Top 10 Biotechs for Innovation (February 16, 2011)
Gamers Forecast Use of Mobile Devices and Social Networks to Accelerate Medical Research (January 31, 2011)
Myelin Repair Foundation announces 40+ drug candidate repurposing opportunities for myelin repair. (January 10, 2011)
The Ultimate Experiment: Can Gaming Technology Resuscitate Medical Research? (PDF). (September 7, 2010)
Notable Foundations Join Forces to Support Accelerated Drug Development Model(PDF). (March 25, 2010) Slides & transcript from Webinar on “Developing Cures with Less Time & Capital” (March 25, 2010)
New Patient Advocacy Initiative Calls for Accountability in Medical Research, Asks “Where Are The Cures?” (February 16, 2010)
Myelin Repair Foundation Names Mike Gresser, Ph.D. as Chief Scientific Officer. (January 8, 2010)
Myelin Repair Foundation Announces Chemistry Collaboration with Dalton Pharma Services. (October 22, 2008)
Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership. (May 27, 2008)
Myelin Repair Foundation Names Six Senior Pharma Execs to Drug Discovery Advisory Group (DDAG). (February 6, 2008)
Myelin Repair Foundation Appoints Vice President of Drug Discovery. (January 31, 2007)
Scientific American Names Scott Johnson Among Top 50 Worldwide for Innovations in Multiple Sclerosis Research. (November 6, 2006)
Myelin Repair Foundation Receives $1.2 Million Grant from Robert Wood Johnson Foundation to Further Accelerated Scientific Research Model. (September 21, 2005)
Myelin Repair Foundation Raises First $5 Million: Omidyar Network Caps First Round Funding. (July 18, 2005)
Scientists Identify Molecular "Switches" Affecting Myelin Repair in Multiple Sclerosis. (June 14, 2005)


Visit our YouTube Channel and subscribe to watch our newest videos.

Overview Videos

  • Myelin Repair Foundation Donor Profile: Dr. John B. Simpson

  • Mendel's Pod: When Drug Discovery Gets Personal

  • 12Gurus 2012: Where Are the Cures?

    Scott Johnson at 12gurus:Health 2012 from 12gurus on Vimeo.

  • Where Are The Cures?

  • Myelination in Action

  • MRF's Translational Medicine Platform

  • Making Connections for a Cure: A New Myelin Repair Foundation Video (August 2010)

  • A Bold New Research Model (May 2008)

  • Five Approaches to Myelin Repair (May 2006)


Focus on Biomarkers

The Myelin Repair Foundation is identifying biomarkers to help accelerate myelin repair treatments.